Advertisement

Clinical Characteristics of Chlamydia pneumoniae Infection

  • Francis P. V. Maesen
  • Benjamin I. Davies

Abstract

The symptoms of Chlamydia pneumoniae infection are mostly derived from case reports and descriptions of outbreaks in which the diagnosis of infection has been made from the results of serological tests showing either high or rising titers of antibody to C. pneumoniae, suggesting that the patients had suffered from an acute or an asymptomatic form of respiratory infection. The micro-immunofluorescence test showing IgM and IgG antibodies is considered the golden standard in the serology of these infections. A fourfold rise in IgM antibody titers or a single titer of 1:16 or greater are considered evidence of recent infection as it is a single IgG titer > 1:512. If the IgM antibody titer is negative and the IgG titer is between 1:16 and 1:512 it is generally supposed that the patient has had an infection with C. pneumoniae in the past [3]. If the relatively insensitive complement fixation test (CFT) technique has been used with the non-specific genus antigen then an infection is assumed if there is a fourfold rise in serum antibody titer in the course of a period of 10 days to 4 weeks, and certainly if the CFT titer is greater than 1:64 Sometimes the patients fail completely to mount any form of complement fixing antibody response [8].

Keywords

Chronic Fatigue Syndrome Complement Fixation Test Maxillary Sinusitis Coronary Arterial Disease Chlamydia Psittaci 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Aldous MB, Grayston JT, Wang SP, Foy 14M (1992) Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle Families, 1966–1979. J Infect Dis 166: 646–649PubMedCrossRefGoogle Scholar
  2. 2.
    Atmar RL, Greenberg SB (1989) Pneumonia caused by Mycoplasma pneumoniae and the TWAR agent. Semin Respir Infect 4: 19–31PubMedGoogle Scholar
  3. 3.
    Beaty CD, Grayston JT, Wang SP et al (1991) Chlamydia pneumoniae, strain TWAR, infection in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 144: 1408–1410Google Scholar
  4. 4.
    Berdal BP, Fields PI, Mitchell SH, Hoddevik G (1990) Isolation of Chlamydia pneumoniae during an adenovirus outbreak In: Chlamydia infections. Bowie WR et al (eds), Cambridge University Press, Cambridge pp 445–448Google Scholar
  5. 5.
    Berdal BP, Scheel O, Ogaard AR, Hoel T, Gutteberg TJ, Anestad G (1992) Spread of subclinical Chlamydia pneumoniae infection in a closed community. Scand J Infect Dis 24: 431–436PubMedCrossRefGoogle Scholar
  6. 6.
    Blasi F, Cosentini R, Denti F, Allegra L (1994) Chlamydia pneumoniae infection in two unrelated families. Eur Respir J 7: 102–4CrossRefGoogle Scholar
  7. 7.
    Blasi F, Legnani D, Lombardo VM, Negretto GG, Magliano E, Pozzoli R, Chiodo F, Fasoli A, Allegra L (1993) Chlamydia pneumoniae infection in acute exacerbations of COPD. Eur Respir J 6: 19–22PubMedGoogle Scholar
  8. 8.
    Bourke SJ (1993) Chlamydial respiratory infections: common but difficult to diagnose. BMJ 306: 1219–1220PubMedCrossRefGoogle Scholar
  9. 9.
    Erntell M, Ljunggren K, Gadd T, Persson K (1989) Erythema nodosum–a manifestation of Chlamydia pneumoniae (strain TWAR) infection. Scand J Infect Dis 21: 693–696PubMedCrossRefGoogle Scholar
  10. 10.
    Grayston JT, Kuo CC, Wang SP, Altman J (1986) A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med 315: 161–168PubMedCrossRefGoogle Scholar
  11. 11.
    Grayston JT, Campbell LA, Kuo CC, Mordhorst CH, Saikku P, Thom DH (1990) A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 161: 618–625PubMedCrossRefGoogle Scholar
  12. 12.
    Grayston JT (1993) Chlamydia in atherosclerosis. Circulation 87: 1408–1409Google Scholar
  13. 13.
    Haidl S, Ivarsson S, Bjerre I, Persson K (1992) Guillain Barré Syndrome after Chlamydia pneumoniae infection. N Engl J Med 326: 576–577PubMedGoogle Scholar
  14. 14.
    Hahn DL (1993) Another possible risk factor for airway disease. Chest 104: 649PubMedGoogle Scholar
  15. 15.
    Hammerschlag MR, Qumei KK, Roblin PM (1992) In vitro activities of azithromycin, clarithromycin, L-ofloxacin and other antibiotics against Chlamydia pneumoniae. Antimicrob Agents Chemother 36: 1573–1574PubMedGoogle Scholar
  16. 16.
    Kleemola M, Saikku P, Viasakorpi R, Wang SP, Grayston JT (1988) Epidemics of pneumonia caused by TWAR, a new Chlamydia organism, in military trainees in Finland J Infect Dis 157: 230–236PubMedCrossRefGoogle Scholar
  17. 17.
    Komaroff AL, Wang SP, Lee J, Grayston JT (1992) No association of chronic Chlamydia pneumoniae infection with chronic fatigue syndrome. J Infect Dis 165: 184PubMedCrossRefGoogle Scholar
  18. 18.
    Linnanmäki E, Leinonen M, Mattila K, Nieminen MS, Valtonen V, Saikku P (1993) Chlamydia pneumoniae specific circulating immune complexes in patients with chronic coronary heart disease. Circulation 87: 1130–1134PubMedGoogle Scholar
  19. 19.
    Manie TJ, Harczy M, Mann 0E, Landymore RW, Raza A, Wang SP, Grayston JT (1990) Culture-negative endocarditis probably due to Chlamydia pneumoniae. J Infect Dis 161: 127–129CrossRefGoogle Scholar
  20. 20.
    Marrie TJ, Grayston JT, Wang SP, Kuo CC (1987) Pneumonia associated with the TWAR strain of Chlamydia. Ann Intern Med 106: 5007–5011Google Scholar
  21. 21.
    Marrie TJ (1993) Chlamydia pneumoniae. Thorax 48: 1–4PubMedCrossRefGoogle Scholar
  22. 22.
    Maesen FPV, Davies BI, Costongs MAL (1992) Are high serum titres against Chlamydia pneumoniae significant in patients with community-acquired pneumonia? Eur Respir J [Suppl 151: 343Google Scholar
  23. 23.
    Mordhorst CH, Wang SP, Grayston JT (1992) Outbreak of Chlamydia pneumoniae infection in four farm families. Eur J Clin Microbiol Infect Dis 11: 617–620PubMedCrossRefGoogle Scholar
  24. 24.
    Rumbak MJ, Baselski V, Belenchia JM, Griffin JP (1993) Case report: acute postoperative respiratory failure caused by Chlamydia pneumoniae and diagnosed by bronchoalveolar lavage. Am J Med Sci 6: 390–393CrossRefGoogle Scholar
  25. 25.
    Saikku P, Wang SP, Kleemola M, Brander E, Rusanen E, Grayston JT (1985) An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci. J Infect Dis 151: 832–839PubMedCrossRefGoogle Scholar
  26. 26.
    Saikku P, Mattila K, Nieminen MS, Huttunen JK, Leinonen M, Ekman MR, Makela PH, Valtona V (1988) Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet ii: 983–985CrossRefGoogle Scholar
  27. 27.
    Saikku P, Ruutu P, Leinonen M, Panelius J, Tupasi TE, Grayston JT (1988) Acute lower respiratory tract infection associated with Chlamydial TWAR antibody in filipino children. J Infect Dis 158: 1095–1097PubMedCrossRefGoogle Scholar
  28. 28.
    Shor A, Kuo CC, Patton DL (1992) Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J 82: 158–161PubMedGoogle Scholar
  29. 29.
    Stolk-Engelaar MVM, Peeters MF (1990) Heeft Chlamydia TWAR betekenis in Nederland ? Ned Tijdschr Geneeskd 134: 1094–1097PubMedGoogle Scholar
  30. 30.
    Sundelöf B, Gnarpe H, Gnarpe J (1993) An unusual manifestation of Chlamydia pneumoniae infection: meningitis, hepatitis, iritis and atypical erythema nodosum. Scand J Infect Dis 25: 259–261PubMedCrossRefGoogle Scholar
  31. 31.
    Thom DH, Grayston JT (1991) Infections with Chlamydia pneumoniae strain TWAR. Clin Chest Med 12: 245–256PubMedGoogle Scholar
  32. 32.
    Thom DH, Grayston JT, Siscovick DS, Wang SP, Weiss NS, Daling JR (1992) Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 268: 68–72PubMedCrossRefGoogle Scholar
  33. 33.
    Torres A, El-Ebiary M (1993) Relevance of Chlamydia pneumoniae in community-acquired respiratory infections. Eur Respir J 6: 7–8PubMedGoogle Scholar
  34. 34.
    Van den Abeele AM, Van Renterghem L, Willems K, Plum J (1992) Prevalence of antibodies to Chlamydia pneumoniae in a Belgian population. J Infect 25 [Suppl 11: 87–90Google Scholar
  35. 35.
    Wesslen L, Pahlson C, Friman G, Fohlman J, Lindquist O, Johansson C (1992) Myocarditis caused by Chlamydia pneumoniae ( TWAR) and sudden unexpected death in a Swedish elite orienteer. Lancet 340: 427–428PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia, Milano 1995

Authors and Affiliations

  • Francis P. V. Maesen
  • Benjamin I. Davies

There are no affiliations available

Personalised recommendations